Continuum Advisory’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-354
Closed -$48.8K 574
2025
Q1
$48.8K Sell
354
-19
-5% -$2.42K 0.01% 685
2024
Q4
$44.1K Buy
373
+14
+4% +$1.63K 0.01% 689
2024
Q3
$43.5K Sell
359
-239
-40% -$25K 0.01% 682
2024
Q2
$58.8K Sell
598
-28
-4% -$2.85K 0.01% 587
2024
Q1
$61.4K Buy
+626
New +$67.5K 0.01% 570

Other funds holding CAH

Continuum Advisory's CAH Position: Q2 2025 in Review

Continuum Advisory sold out of Cardinal Health (CAH) in Q2 2025, closing a stake of 354 shares — an estimated $48.8K sold.

Continuum Advisory first reported a position in CAH in Q1 2024 and held it in 5 quarters. The position peaked at $61.4K in Q1 2024. 1,253 funds tracked by Wall St. Rank hold CAH as of Q2 2025.

  • Continuum Advisory reported no remaining Cardinal Health position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 354 Cardinal Health shares in Q2 2025, an estimated $48.8K.
  • Continuum Advisory first reported a position in Cardinal Health in Q1 2024 and held it in 5 quarters.
  • Continuum Advisory's Cardinal Health position peaked at $61.4K in Q1 2024.
  • 1,253 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.